Grason Stadler has announced significant updates to its GSI AudioStar Pro.
In Part 5 of this 5-part series, The Hearing Review’s roundtable of hearing care professionals discusses alternate dispensing channels, personal sound amplification products (PSAPs), Internet and mail-order hearing aids, and how to advise consumers and clients about these products.
US hearing aid unit sales in the first quarter of 2014 increased by less than a percentage point (0.95%) for the total market, and by one-tenth of a percent (0.12%) for the commercial (non-VA) sector compared to the same period last year, according to recently released HIA statistics.
In Part 4 of this 5-part series, our roundtable takes on the topics of marketing and outreach to physicians, changing attitudes about hearing aids in younger patients, and a greater willingness to try new technology.
School hearing tests cannot effectively detect adolescent high-frequency hearing loss, which is typically caused by loud noise exposure, according to researchers at Penn State College of Medicine.
A new treatment for BTE and RIC/RITE receiver tubing and wire covers is designed to dye the hearing aid plumbing for an even more invisible, personalized match to the individual’s skin color.
Hearing care professionals are faced with several key changes and challenges in their practices, but are also being presented with new opportunities for growth. This article analyzes results from HR’s 2013 survey and, in many cases, compares the results with previously published surveys and historical data from up to 30 years ago.
Lyric3 technology is designed to provide more natural sound; the company reports that 94% of users would recommend Lyric to a friend or loved one.
CareCredit and The Hearing Review hosted a dinner on the eve of the AAA convention that highlighted the fast-paced changes in hearing healthcare and also posed some potential solutions for the future.
The Senate has approved HR 4302 which delays the ICD-10 implementation date to October 1 of next year, staving off the projected 24% cut to Medicare Part B payments and extending the therapy caps exceptions process through March 2015.